Ledger.Open graph →
SEC Form D · filed March 2, 2016

Neurovance, Inc

Offering
$4.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

William T. Pappafotopoulos · Cambridge, MAExecBrigitte A. Smith · Melbourne VIC, Channel IslandsDirectorTimothy J. Barberich · Concord, MADirectorCampbell A. Murray · Cambridge, MADirectorPaul A. Weiss · Madison, WIDirectorAnthony A. Mckinney · Cambridge, MAExec · DirectorDaniel A. Omstead · Boston, MADirectorJeffrey L. Bailey · Cambridge, MADirectorRoss A. Reife · Cambridge, MAExecAlbert L. Sokol · Boston, MAExecSusan Oh · Denver, CODirectorJeri P. Wechsler · Houston, TXExecR. D. Newton · Plano, TXDirectorColin Carr · Lone Tree, COExecRobert L. Riedl · Appleton, WIExecChris J. O'Reilly · Atlanta, GADirectorGreg A. Beloff · Cambridge, MAExecBrett D. Forman · Palm Beach, FLDirectorMichael A. Groneberg · MINNEAPOLIS, MNDirectorGeoff Huber · MINNEAPOLIS, MNExec · DirectorTroy L. Beckett · Houston, TXExec · DirectorCharles J. Neverdowski · Houston, TXExecAnna M. Lantz · Houston, TXDirectorPaul Stevenson · Smiths, BermudaDirectorCharles Thomas · Grand Cayman, Cayman IslandsDirectorDaniel Grugan · Wilmington, DEExecJohn Mcpheters · New York, NYDirectorGreg A. Beloff · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗